Paul Glue
Impact in
- Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
- Hepatology top 0.5%
- Hepatitis C virus research
Papers in
-
- Tryptophan and brain disorders 29
-
- Epilepsy research and treatment 16
- Schizophrenia research and treatment 16
- Electroconvulsive Therapy Studies 13
- Co-authors
- David NuttSamir K. GuptaPhilip B. MitchellNeil McNaughtonAndrew A. SomogyiColleen LooChristopher BanfieldRobert P. Clement
- Journals
- Journal of Psychopharmacology (19 papers)Clinical Pharmacology & Therapeutics (13 papers)The Journal of Clinical Pharmacology (12 papers)British Journal of Clinical Pharmacology (12 papers)Australian & New Zealand Journal of Psychiatry (7 papers)
- Partner nations
- New ZealandUnited StatesUnited Kingdom
In The Last Decade
Paul Glue
222 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 152
- Biological Psychiatry 845
- Hepatology 1.0k
- Pharmacology 1.5k
- Behavioral Neuroscience 245
- Psychiatry and Mental health 1.0k
Countries citing papers authored by Paul Glue
This map shows the geographic impact of Paul Glue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Glue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Glue more than expected).
Fields of papers citing papers by Paul Glue
This network shows the impact of papers produced by Paul Glue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Glue. The network helps show where Paul Glue may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Glue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 9 | |
| 7 | 2023 | 17 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 3 | |
| 10 | 2020 | 5 | |
| 11 | 2019 | 13 | |
| 12 | 2019 | 5 | |
| 13 | Influence of law changes affecting synthetic cannabinoid availability and frequency of hospital presentations: 4-year national survey. | 2016 | 12 |
| 14 | Influence of rural background and rural medical training on postgraduate medical training and location in New Zealand. | 2014 | 10 |
| 15 | Academic performance and career choices of older medical students at the University of Otago. | 2011 | 9 |
| 16 | 2009 | 6 | |
| 17 | 2009 | 23 | |
| 18 | 2008 | 33 | |
| 19 | 1992 | 18 | |
| 20 | 1988 | 13 |
About Paul Glue
Paul Glue is a scholar working on Biological Psychiatry, Psychiatry and Mental health, Medical Terminology, Pharmacology and Behavioral Neuroscience, having authored 230 papers that have together received 6.5k indexed citations. Recurring topics across this work include Treatment of Major Depression (45 papers), Tryptophan and brain disorders (29 papers), Pharmacological Effects and Toxicity Studies (24 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (24 papers), Neurotransmitter Receptor Influence on Behavior (17 papers), Epilepsy research and treatment (16 papers), Schizophrenia research and treatment (16 papers) and Electroconvulsive Therapy Studies (13 papers). The work is most often cited by research in Biological Psychiatry (845 citations), Hepatology (1.0k citations), Pharmacology (1.5k citations), Behavioral Neuroscience (245 citations) and Psychiatry and Mental health (1.0k citations). Paul Glue has collaborated with scholars based in New Zealand, United States and United Kingdom. Frequent co-authors include David Nutt, Samir K. Gupta, Philip B. Mitchell, Neil McNaughton, Andrew A. Somogyi, Colleen Loo, Christopher Banfield, Robert P. Clement, David Nutt and Verònica Gálvez. Their work appears in journals such as Journal of Psychopharmacology, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and Australian & New Zealand Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.